Clean Science & Technology Ltd

Clean Science Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Clean Science & Technology Ltd

₹ 763 -0.92%
13 Jul 9:24 a.m.
cleanscience.co.in BSE: 543318 NSE: CLEAN
About

Incorporated in 2003, Clean Science and Technology Ltd is one of the leading chemical manufacturers globally. It manufactures functionally critical specialty chemicals such as Performance Chemicals (MEHQ, BHA, and AP), Pharmaceutical Intermediates (Guaiacol and DCC), and FMCG Chemicals (4-MAP and Anisole). [1]

Key Points

Product Segments (FY26):[1][2]
a) Performance Chemicals (72%):
The company manufactures Monomethyl Ether of Hydroquinone (MEHQ), which is used as a polymerization inhibitor in acrylic acids, acrylic esters, super absorbent polymers (diapers and sanitary pads), Butylated Hydroxy Anisole (BHA), used as anti-oxidant in food and feed industry, Ascorbyl Palmitate (AP), used in infant food formulations, breakfast cereals, and cosmetics, Tertiary Butyl Hydroquinone (TBHQ) used as a stabilizer in the oil industry and Hindered Amine light Stabilizers (HALS), used in water treatment and UV stabilization in a variety of polymers. TBHQ ranks 2nd globally, while the rest of the products are ranked no.1.
b) Pharma & Agro Intermediates (19%):
It manufactures Guaiacol (ranked 2nd globally & 1st in India), a precursor to manufacture APIs for cough syrup and key raw material to produce Vanillin, Dicyclohexyl Carbodiimide (ranked 2nd globally & 1st in India), used as a reagent in anti-retroviral, Veratrole (amongst largest in India), an intermediate in agrochemical industry and DHDT (No 1 in India), used as a reagent in anti-retroviral.
c) FMCG Chemicals (9%):
It manufactures 4-Methoxy Acetophenone (4-MAP) (No 1 globally), used in UV blockers in sunscreens, and Anisole (No 1 globally), used as a precursor to perfumes, insect pheromones, and pharmaceuticals. The majority of Anisole produced is used for captive consumption.

Website BSE NSE
  • Market Cap ₹ 8,109 Cr.
  • Current Price ₹ 763
  • High / Low ₹ 1,490 / 652
  • Stock P/E 35.3
  • Book Value ₹ 149
  • Dividend Yield 0.79 %
  • ROCE 20.6 %
  • ROE 15.3 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 21.5%

Cons

  • Promoter holding has decreased over last 3 years: -27.2%
  • Working capital days have increased from 144 days to 242 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE 500 Nifty 500 BSE Commodities BSE 250 SmallCap Index BSE 400 MidSmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
217 188 181 195 228 224 238 241 264 243 245 220 249
112 112 106 108 133 129 148 142 159 143 158 147 153
Operating Profit 105 76 75 87 95 95 90 98 105 100 87 72 96
OPM % 48% 40% 41% 44% 42% 42% 38% 41% 40% 41% 36% 33% 38%
13 13 6 8 14 10 11 5 12 13 7 10 3
Interest 0 0 0 0 1 0 0 0 0 0 0 0 0
Depreciation 10 11 11 11 13 16 18 18 17 19 19 19 21
Profit before tax 108 79 69 83 95 89 83 85 100 95 75 63 78
Tax % 25% 25% 25% 25% 26% 26% 29% 23% 26% 26% 26% 27% 25%
81 59 52 63 70 66 59 66 74 70 55 46 58
EPS in Rs 7.58 5.55 4.91 5.89 6.61 6.20 5.53 6.18 6.97 6.59 5.22 4.32 5.48
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
241 393 419 512 685 936 791 967 957
167 257 234 253 385 533 459 579 602
Operating Profit 74 137 186 260 300 403 332 388 355
OPM % 31% 35% 44% 51% 44% 43% 42% 40% 37%
5 11 11 25 30 30 41 39 33
Interest 1 0 0 0 0 1 1 1 0
Depreciation 8 11 14 17 25 36 46 69 78
Profit before tax 70 137 182 267 305 396 326 357 310
Tax % 30% 28% 23% 26% 25% 25% 25% 26% 26%
49 98 140 198 228 295 244 264 230
EPS in Rs 345.41 689.84 1,051.67 18.68 21.51 27.78 22.97 24.88 21.61
Dividend Payout % 12% 15% 2% 134% 15% 18% 22% 24% 19%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 1%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: 3%
3 Years: -8%
TTM: -13%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -16%
1 Year: -46%
Return on Equity
10 Years: %
5 Years: 23%
3 Years: 19%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1 1 1 11 11 11 11 11 11
Reserves 186 271 341 529 758 999 1,193 1,406 1,573
1 3 3 0 0 2 2 2 2
48 53 85 120 156 140 191 181 197
Total Liabilities 236 327 430 660 925 1,152 1,396 1,600 1,783
102 127 166 186 296 460 636 715 760
CWIP 2 4 3 55 44 20 57 30 118
Investments 18 75 133 232 191 353 339 381 405
114 121 128 187 394 318 364 474 500
Total Assets 236 327 430 660 925 1,152 1,396 1,600 1,783

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
45 85 160 193 127 279 236 214 275
-17 -94 -105 -187 -79 -270 -185 -152 -203
-5 -11 -55 -6 -0 -55 -53 -53 -64
Net Cash Flow 23 -20 -0 0 49 -45 -2 10 8
Free Cash Flow 13 46 110 109 -12 96 10 72 74
CFO/OP 91% 88% 109% 100% 65% 93% 94% 80% 103%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 60 55 61 53 82 57 76 77 79
Inventory Days 93 79 98 156 143 122 163 156 157
Days Payable 85 48 101 180 166 90 139 103 118
Cash Conversion Cycle 69 87 58 29 59 89 99 129 118
Working Capital Days 60 62 33 32 90 68 86 105 242
ROCE % 59% 59% 61% 47% 44% 29% 27% 21%

Insights

In beta
Mar 2018 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
India Revenue Share
% ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Performance Chemicals Segment Share
% ・Standalone data
R&D Scientists Count
Count
Number of Customers
Count
Number of Manufacturing Units
Count
R&D Expenditure (Percentage of Turnover)
% ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

14 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
74.98% 74.98% 74.98% 74.98% 74.98% 74.97% 74.97% 74.96% 74.96% 50.96% 50.96% 51.29%
5.84% 6.01% 5.92% 5.88% 6.05% 5.83% 5.98% 6.07% 6.21% 11.14% 10.01% 13.38%
6.41% 5.23% 5.13% 5.04% 4.55% 4.77% 5.46% 5.77% 5.92% 18.97% 19.76% 17.14%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01%
12.78% 13.79% 13.98% 14.11% 14.42% 14.43% 13.59% 13.21% 12.91% 18.91% 19.26% 18.17%
No. of Shareholders 2,66,9712,85,2592,78,6532,79,3952,73,8412,54,6292,46,7982,37,0162,25,4842,39,9742,43,6062,37,113

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls